Table 2 Baseline clinical features and treatment outcomes of the patients
| Â | Total |
|---|---|
Number of patients | 81 |
Mean Age, years (range) | 67.6 ± 8.2 (50–83) |
Male / Female | 49 (60.5%) / 32 (39.5%) |
Smoking status | |
 Ever (current / ex-smoker) | 32 (39.5%) |
 Never | 49 (60.5%) |
Baseline | |
 Best-corrected visual acuity, ETDRS letters | 50.6 ± 20.7 |
 Total foveal thickness, μm | 425.6 ± 199.4 |
 Vascular lesion area, mm2 | 3.5 ± 2.1 |
Treatment outcomes at month 12 | |
 Best-corrected visual acuity, ETDRS letters | 55.6 ± 25.0 |
 Visual gain ≥15 letters | 25 (30.9%) |
 Total foveal thickness, μm | 344.4 ± 277.2 |
 Dry status on OCT | 34 (42.0%) |
 PED regression on OCT | 32 (39.5%) |
 Polyp regression on ICGA | 19 / 55 (34.5%) |
 Number of injections | 5.7 ± 1.9 |